United Health Products, Inc. (UEEC)
USD 0.06
(-0.16%)
USD 0.06
(-0.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.62 Million USD | -55.56% |
| 2022 | -1.68 Million USD | 94.59% |
| 2021 | -31.16 Million USD | -91.71% |
| 2020 | -16.25 Million USD | -128.64% |
| 2019 | -7.11 Million USD | -18.39% |
| 2018 | -6 Million USD | -542.39% |
| 2017 | -934.96 Thousand USD | -74.52% |
| 2016 | -535.73 Thousand USD | 79.33% |
| 2015 | -2.59 Million USD | -20.87% |
| 2014 | -2.14 Million USD | -90.38% |
| 2013 | -1.12 Million USD | -300.25% |
| 2012 | -281.41 Thousand USD | 82.28% |
| 2011 | -1.58 Million USD | 45.15% |
| 2010 | -2.89 Million USD | -218.2% |
| 2009 | -910 Thousand USD | -228.89% |
| 2008 | -276.68 Thousand USD | -21.21% |
| 2007 | -228.26 Thousand USD | -19.41% |
| 2006 | -191.16 Thousand USD | -1133.21% |
| 2005 | -15.5 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -451.93 Thousand USD | 4.23% |
| 2024 Q2 | -432.02 Thousand USD | 4.41% |
| 2023 FY | -2.62 Million USD | -55.56% |
| 2023 Q1 | -1.2 Million USD | 40.51% |
| 2023 Q2 | -522.91 Thousand USD | 56.56% |
| 2023 Q3 | -485.73 Thousand USD | 7.11% |
| 2023 Q4 | -471.91 Thousand USD | 2.84% |
| 2022 Q4 | -2.02 Million USD | -346.59% |
| 2022 Q1 | -974.02 Thousand USD | 33.88% |
| 2022 Q2 | -1 Million USD | -3.0% |
| 2022 Q3 | 820.56 Thousand USD | 181.79% |
| 2022 FY | -1.68 Million USD | 94.59% |
| 2021 Q1 | -27.04 Million USD | -423.04% |
| 2021 FY | -31.16 Million USD | -91.71% |
| 2021 Q4 | -1.47 Million USD | -103.36% |
| 2021 Q3 | -724.41 Thousand USD | 44.47% |
| 2021 Q2 | -1.3 Million USD | 95.18% |
| 2020 FY | -16.25 Million USD | -128.64% |
| 2020 Q4 | -5.17 Million USD | 43.92% |
| 2020 Q3 | -9.22 Million USD | -1230.54% |
| 2020 Q2 | -693.05 Thousand USD | -10.74% |
| 2020 Q1 | -625.82 Thousand USD | 74.63% |
| 2019 FY | -7.11 Million USD | -18.39% |
| 2019 Q1 | -2.98 Million USD | -324.28% |
| 2019 Q4 | -2.46 Million USD | -464.9% |
| 2019 Q3 | -436.66 Thousand USD | 38.76% |
| 2019 Q2 | -713 Thousand USD | 76.12% |
| 2018 FY | -6 Million USD | -542.39% |
| 2018 Q4 | -703.75 Thousand USD | -76.92% |
| 2018 Q1 | -3.99 Million USD | -445.32% |
| 2018 Q2 | -914.54 Thousand USD | 77.08% |
| 2018 Q3 | -397.79 Thousand USD | 56.5% |
| 2017 Q4 | -731.68 Thousand USD | -420.74% |
| 2017 Q3 | -140.5 Thousand USD | -17.32% |
| 2017 Q2 | -119.76 Thousand USD | -330.35% |
| 2017 FY | -934.96 Thousand USD | -74.52% |
| 2017 Q1 | 51.99 Thousand USD | 128.49% |
| 2016 Q1 | -117.88 Thousand USD | 74.66% |
| 2016 Q3 | -173.83 Thousand USD | -182.51% |
| 2016 Q4 | -182.48 Thousand USD | -4.97% |
| 2016 FY | -535.73 Thousand USD | 79.33% |
| 2016 Q2 | -61.53 Thousand USD | 47.81% |
| 2015 Q1 | -1.57 Million USD | 5.95% |
| 2015 FY | -2.59 Million USD | -20.87% |
| 2015 Q4 | -465.18 Thousand USD | -15.21% |
| 2015 Q3 | -403.75 Thousand USD | -166.64% |
| 2015 Q2 | -151.42 Thousand USD | 90.36% |
| 2014 Q2 | -215.68 Thousand USD | -29.64% |
| 2014 Q4 | -1.67 Million USD | -1730.5% |
| 2014 Q3 | -91.28 Thousand USD | 57.67% |
| 2014 FY | -2.14 Million USD | -90.38% |
| 2014 Q1 | -166.36 Thousand USD | 56.03% |
| 2013 Q2 | -103.08 Thousand USD | -80.13% |
| 2013 Q1 | -57.22 Thousand USD | 42.39% |
| 2013 Q4 | -378.34 Thousand USD | 35.62% |
| 2013 Q3 | -587.71 Thousand USD | -470.11% |
| 2013 FY | -1.12 Million USD | -300.25% |
| 2012 Q3 | -56.17 Thousand USD | 3.06% |
| 2012 FY | -281.41 Thousand USD | 82.28% |
| 2012 Q4 | -99.33 Thousand USD | -76.82% |
| 2012 Q2 | -57.94 Thousand USD | 14.73% |
| 2012 Q1 | -67.95 Thousand USD | 88.05% |
| 2011 Q3 | -208.04 Thousand USD | 16.14% |
| 2011 FY | -1.58 Million USD | 45.15% |
| 2011 Q1 | -563.62 Thousand USD | -19.23% |
| 2011 Q2 | -248.09 Thousand USD | 55.98% |
| 2011 Q4 | -568.6 Thousand USD | -173.31% |
| 2010 Q4 | -472.72 Thousand USD | 55.51% |
| 2010 Q3 | -1.06 Million USD | 14.44% |
| 2010 Q2 | -1.24 Million USD | -946.9% |
| 2010 Q1 | -118.61 Thousand USD | 68.42% |
| 2010 FY | -2.89 Million USD | -218.2% |
| 2009 Q1 | -74.3 Thousand USD | 17.94% |
| 2009 FY | -910 Thousand USD | -228.89% |
| 2009 Q4 | -375.65 Thousand USD | -16468.37% |
| 2009 Q3 | 2295.00 USD | 100.52% |
| 2009 Q2 | -443.92 Thousand USD | -497.41% |
| 2008 Q4 | -90.54 Thousand USD | 28.64% |
| 2008 Q2 | -28.87 Thousand USD | 1.47% |
| 2008 Q3 | -126.88 Thousand USD | -339.44% |
| 2008 Q1 | -29.3 Thousand USD | 20.82% |
| 2008 FY | -276.68 Thousand USD | -21.21% |
| 2007 Q2 | -70.16 Thousand USD | 10.79% |
| 2007 FY | -228.26 Thousand USD | -19.41% |
| 2007 Q3 | -55.38 Thousand USD | 21.06% |
| 2007 Q1 | -78.65 Thousand USD | -74.03% |
| 2007 Q4 | -37.01 Thousand USD | 33.18% |
| 2006 Q1 | -20.95 Thousand USD | -184.95% |
| 2006 Q3 | -61.71 Thousand USD | 2.25% |
| 2006 Q4 | -45.19 Thousand USD | 26.77% |
| 2006 FY | -191.16 Thousand USD | -1133.21% |
| 2006 Q2 | -63.13 Thousand USD | -201.22% |
| 2005 Q4 | -7355.00 USD | -45.3% |
| 2005 Q3 | -5062.00 USD | 0.0% |
| 2005 FY | -15.5 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -183.017% |
| Ansell Limited | 76.5 Million USD | 103.429% |
| Ansell Limited | 76.5 Million USD | 103.429% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 110.804% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | -60.913% |
| Psykey, Inc. | -1.32 Million USD | -98.139% |
| ConvaTec Group Plc | 130.3 Million USD | 102.013% |
| ConvaTec Group Plc | 130.3 Million USD | 102.013% |
| Encision Inc. | -691.78 Thousand USD | -279.204% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1749.833% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -1019.304% |
| Innovative MedTech Inc. | -7.93 Million USD | 66.957% |
| LifePoint, Inc. | -15.23 Million USD | 82.777% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 61.485% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -453.432% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -855.841% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -471.483% |
| SmileDirectClub, Inc. | -86.4 Million USD | 96.964% |
| Sector 10, Inc. | 7036.00 USD | 37383.499% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.131% |
| SheerVision, Inc. | -71.37 Thousand USD | -3575.279% |
| Vasamed, Inc. | -4.88 Million USD | 46.334% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | -9.831% |
| Yubo International Biotech Limited | -1.2 Million USD | -117.741% |